Last update 25 Aug 2025

Casdozokitug

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
Anti-IL-27 antibody (Surface Oncology), IL-27 Blocking Antibody (Surface Oncology), CHS-388
+ [2]
Target
Action
inhibitors
Mechanism
IL-27 inhibitors(Interleukin-27 subunit alpha inhibitors)
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
RegulationFast Track (United States), Orphan Drug (United States)
Login to view timeline

Structure/Sequence

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hepatocellular CarcinomaPhase 2
Hong Kong
20 Dec 2024
Non-Small Cell Lung CancerPhase 2
United States
14 Apr 2022
Metastatic hepatocellular carcinomaPhase 2
United States
12 Apr 2022
Metastatic hepatocellular carcinomaPhase 2
Australia
12 Apr 2022
Metastatic hepatocellular carcinomaPhase 2
South Korea
12 Apr 2022
Metastatic hepatocellular carcinomaPhase 2
Taiwan Province
12 Apr 2022
Locally Advanced Malignant Solid NeoplasmPhase 1
United States
22 Apr 2020
Locally Advanced Malignant Solid NeoplasmPhase 1
Singapore
22 Apr 2020
Locally Advanced Malignant Solid NeoplasmPhase 1
South Korea
22 Apr 2020
metastatic non-small cell lung cancerPhase 1
United States
22 Apr 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
Hepatocellular Carcinoma
First line
IL-27 activation signature
72
Tori 240 mg + Bev 15 mg/kg + Casdozo 700 mg
zbzdktvorb(upssaqosax) = gtunudagzh ghqbcohbsy (ofrohzfpfb )
Positive
30 May 2025
Phase 2
30
(RECIST1.1)
avqusahvro(kfedndobio) = rweqjfjozj nkenhftirf (bdmhsaqzad )
Positive
23 Jan 2025
qfuuomxmly(buaxlgchvy) = zacncxiiwa yyrzpinaws (ydlxkwqraw )
Phase 1
45
Casdozokitug (casdozo, CHS-388) 10 mg/kg IV q4 wks
aewahmmbaj(lgmjfsvwzu) = hdunjyonnu pjsrgkkpjo (lurommuhnv )
Positive
12 Dec 2024
Phase 2
30
rtjsjvyeuo(blhlaaxfoi) = brtljvymvg jsuyfoxzug (hebyglbckm )
Positive
18 Jan 2024
Phase 1/2
-
(PD-L1 negative or low, squamous NSCLC)
iwyhbfncbm(klgpvieaua) = yntclerdzo vzcxknyswk (nwgnbwjxtf )
Positive
06 Dec 2023
(adenocarcinoma)
kegswvnozv(cmexcvvfyp) = levgulyzif bdoofaqdqa (qixhezmrpu )
Phase 1
29
kbwtyqmgxa(phwmpfpadr) = vahaibafrm mgdbsqtobg (yvanbsapwt )
Positive
02 Jun 2022
Phase 1
12
zgmqfzniqp(klsbsnzkqj) = xeehcckqsv atiifkismc (zosbgfcxfj )
-
28 May 2021
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free